Research Article
Ubenimex Combined with Pemetrexed Upregulates SOCS1 to Inhibit Lung Adenocarcinoma Progression via the JAK2-STAT3 Signaling Pathway
Figure 4
Pathway analysis based on different types of treatments and no treatment using A549 (a, b) and PC-9 (c, d) cells. (a, c) Represent the results on the Western blots, while (b, d) illustrate the relative protein expressions via histogram. for comparison between the treatment groups and the sham group; for comparison between the 1 mg/ml UBE group and the UBE + PEM group.
(a) |
(b) |
(c) |
(d) |